The corticobasal syndrome-Alzheimer's disease conundrum

Expert Review of Neurotherapeutics

Volumn 11, Issue 11, 2011, Pages 1569-1578

  Hassan, Anhar ^a   Whitwell, Jennifer L ^a   Josephs, Keith A ^a  

^a MAYO CLINIC   (United States)

Author keywords

alien limb; Alzheimer's disease; apraxia; corticobasal degeneration; corticobasal syndrome; dementia; myoclonus; rigidity; tau; voxel based morphometry

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; AV 45; BIOCHEMICAL MARKER; FLORBETABEN; FLUORODEOXYGLUCOSE; PITTSBURGH COMPOUND B; RADIOPHARMACEUTICAL AGENT; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APRAXIA; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; CORTICOBASAL SYNDROME; DEGENERATIVE DISEASE; DEMOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GAZE PARALYSIS; GENETIC RISK; HAPLOTYPE; HUMAN; MYOCLONUS; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PROTEIN PHOSPHORYLATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOXEL BASED MORPHOMETRY;

ALZHEIMER DISEASE; BRAIN; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 80054946555     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.153     Document Type: Review

References (85)

1. Boeve BF. Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis. Assoc. Disord. 21(4), S31-S38 (2007)
2. Hu WT, Rippon GW, Boeve BF et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov. Disord. 24(9), 1375-1379 (2009)
3. Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life? Mov. Disord. 24(11), 1593-1599 (2009)
4. Josephs KA, Petersen RC, Knopman DS et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66(1), 41-48 (2006)
5. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48(4), 959-969 (1997)
6. Josephs KA, Holton JL, Rossor MN et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 126(Pt 10), 2291-2303 (2003)
7. Boeve BF, Maraganore DM, Parisi JE et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 53(4), 795-800 (1999)
8. Masellis M, Momeni P, Meschino W et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 129(Pt 11), 3115-3123 (2006)
9. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov. Disord. 14(4), 674-680 (1999)
10. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53(9), 1969-1974 (1999)
11. Alladi S, Xuereb J, Bak T et al. Focal cortical presentations of Alzheimer's disease. Brain 130(Pt 10), 2636-2645 (2007)
12. Doran M, du Plessis DG, Enevoldson TP, Fletcher NA, Ghadiali E, Larner AJ. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol. Sci. 216(1), 127-134 (2003)
13. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 54(Suppl. 5), S15-S19 (2003)
14. Hassan A, Whitwell JL, Boeve BF et al. Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat. Disord. 16(3), 208-214 (2010)
15. Doody RS, Jankovic J. The alien hand and related signs. J Neurol. Neurosurg. Psychiatry 55(9), 806-810 (1992)
16. Gottlieb D, Robb K, Day B. Mirror movements in the alien hand syndrome. Case report. Am. J Phys. Med. Rehabil. 71(5), 297-300 (1992)
17. Josephs KA, Duffy JR, Strand EA et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129(Pt 6), 1385-1398 (2006)
18. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch. Neurol. 18(1), 20-33 (1968)
19. Yu CE, Bird TD, Bekris LM et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch. Neurol. 67(2), 161-170 (2010)
20. Kelley BJ, Haidar W, Boeve BF et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol. Aging 30(5), 739-751 (2009)
21. Josephs KA, Hodges JR, Snowden JS et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 122(2), 137-153 (2011)
22. Ling H, O'Sullivan SS, Holton JL et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133(Pt 7), 2045-2057 (2010)
23. Ball JA, Lantos PL, Jackson M, Marsden CD, Scadding JW, Rossor MN. Alien hand sign in association with Alzheimer's histopathology. J Neurol. Neurosurg. Psychiatry 56(9), 1020-1023 (1993)
24. Chand P, Grafman J, Dickson D, Ishizawa K, Litvan I. Alzheimer's disease presenting as corticobasal syndrome. Mov. Disord. 21(11), 2018-2022 (2006)
25. Eberhard DA, Lopes MB, Trugman JM, Brashear HR. Alzheimer's disease in a case of cortical basal ganglionic degeneration with severe dementia. J Neurol. Neurosurg. Psychiatry 60(1), 109-110 (1996)
26. Golaz J, Bouras C, Hof PR. Motor cortex involvement in presenile dementia: report of a case. J Geriatr. Psychiatry Neurol. 5(2), 85-92 (1992)
27. Horoupian DS, Wasserstein PH. Alzheimer's disease pathology in motor cortex in dementia with lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol. 98(3), 317-322 (1999)
28. Imamura A, Wszolek ZK, Lucas JA, Dickson DW. Corticobasal syndrome with Alzheimer's disease pathology. Mov. Disord. 24(1), 152-153 (2009)
29. Jagust WJ, Davies P, Tiller-Borcich JK, Reed BR. Focal Alzheimer's disease. Neurology 40(1), 14-19 (1990)
30. Kaida K, Takeda K, Nagata N, Kamakura K. Alzheimer's disease with asymmetric parietal lobe atrophy: a case report. J Neurol. Sci. 160(1), 96-99 (1998)
31. Lleo A, Rey MJ, Castellvi M, Ferrer I, Blesa R. Asymmetric myoclonic parietal syndrome in a patient with Alzheimer's disease mimicking corticobasal degeneration. Neurologia 17(4), 223-226 (2002)
32. Osako M, Mochizuki Y, Kugio Y, Mizutani T, Hayashi H. [Autopsy case of atypical type of alzheimer's disease clinically diagnosed as corticobasal degeneration]. Rinsho Shinkeigaku 47(9), 581-584 (2007)
33. Pogacar S, Williams RS. Alzheimer's disease presenting as slowly progressive aphasia. RI Med. J 67(4), 181-185 (1984)
34. Ceccaldi M, Poncet M, Gambarelli D, Guinot H, Bille J. [Progressive severity of left unilateral apraxia in 2 cases of Alzheimer disease]. Rev. Neurol. (Paris) 151(4), 240-246 (1995)
35. Okazaki K, Fu YJ, Nishihira Y et al. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration. Neuropathology 30(2), 140-148 (2010)
36. Litvan I, Agid Y, Goetz C et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 48(1), 119-125 (1997)
37. Dickson DW, Bergeron C, Chin SS et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol. Exp. Neurol. 61(11), 935-946 (2002)
38. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7), 939-944 (1984)
39. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82(4), 239-259 (1991)
40. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. Suppl. 165, 3-12 (1996)
41. Kramer JH, Miller BL. Alzheimer's disease and its focal variants. Semin. Neurol. 20(4), 447-454 (2000)
42. Whitwell JL, Weigand SD, Shiung MM et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 130(Pt 3), 708-719 (2007)
43. Josephs KA, Whitwell JL, Dickson DW et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol. Aging 29(2), 280-289 (2008)
44. Katzman R KC. The Epidemiology of Dementia and Alzheimer's Disease. Terry RD, Bick KL (Eds). Raven Press, New York, NY, USA (1994)
45. Weiner MF, Vega G, Risser RC et al. Apolipoprotein E e4, other risk factors, and course of Alzheimer's disease. Biol. Psychiatry 45(5), 633-638 (1999)
46. van Duijn CM, Stijnen T, Hofman A. Risk factors for Alzheimer's disease: overview of the EURODEM collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J Epidemiol. 20(Suppl. 2), S4-S12 (1991)
47. Hutton M, Lendon CL, Rizzu P et al. Association of missense and 5-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393(6686), 702-705 (1998)
48. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad. Sci. USA 95(13), 7737-7741 (1998)
49. Scaravilli T, Tolosa E, Ferrer I. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov. Disord. 20(Suppl. 12), S21-S28 (2005)
50. Rabinovici GD, Furst AJ, Alkalay A et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 133(Pt 2), 512-528 (2010)
51. Licht EA, McMurtray AM, Saul RE, Mendez MF. Cognitive differences between early-and late-onset Alzheimer's disease. Am. J Alzheimers Dis. Other Demen. 22(3), 218-222 (2007)
52. Green EK, Thaker U, McDonagh AM et al. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain. Neurosci. Lett. 324(2), 113-116 (2002)
53. Houlden H, Baker M, Morris HR et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56(12), 1702-1706 (2001)
54. Bird T. Alzheimer disease overview. In: Gene Reviews. Pagon RA, Bird TE, Dolan CR et al. (Eds). University of Washington, Seattle, WA, USA (2003)
55. Josephs KA, Whitwell JL, Boeve BF et al. Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease. Mov. Disord. 25(9), 1246-1252 (2010)
56. Whitwell JL, Jack CR Jr, Boeve BF et al. Imaging correlates of pathology in corticobasal syndrome. Neurology 75(21), 1879-1887 (2010)
57. Borroni B, Premi E, Agosti C et al. CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder. J Neurol. Neurosurg. Psychiatry 82(8), 834-838 (2011)
58. Pillon B, Blin J, Vidailhet M et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 45(8), 1477-1483 (1995)
59. Soliveri P, Monza D, Paridi D et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 53(3), 502-507 (1999)
60. Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 11(4), 268-273 (2005)
61. Graham NL, Bak T, Patterson K, Hodges JR. Language function and dysfunction in corticobasal degeneration. Neurology 61(4), 493-499 (2003)
62. Cummings JL. Biomarkers in Alzheimer's disease -perspectives for the future. US Neurology 6(1), 23-27 (2010)
63. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2(10), 605-613 (2003)
64. Shaw LM, Vanderstichele H, Knapik-Czajka M et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 65(4), 403-413 (2009)
65. Tapiola T, Alafuzoff I, Herukka SK et al. Cerebrospinal fluid b-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol. 66(3), 382-389 (2009)
66. Koyama M, Yagishita A, Nakata Y, Hayashi M, Bandoh M, Mizutani T. Imaging of corticobasal degeneration syndrome. Neuroradiology 49(11), 905-912 (2007)
67. Schrag A, Good CD, Miszkiel K et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 54(3), 697-702 (2000)
68. Josephs KA, Tang-Wai DF, Edland SD et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch. Neurol. 61(12), 1881-1884 (2004)
69. Jones BF, Barnes J, Uylings HB et al. Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cereb. Cortex 16(12), 1701-1708 (2006)
70. Rusinek H, de Leon MJ, George AE et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology 178(1), 109-114 (1991)
71. Whitwell JL, Jack CR Jr, Przybelski SA et al. Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol. Aging 32(9), 1531-1541 (2009)
72. Whitwell JL, Jack CR Jr, Parisi JE et al. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 130(Pt 4), 1148-1158 (2007)
73. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad. Sci. USA 101(13), 4637-4642 (2004)
74. Wu X, Li R, Fleisher AS et al. Altered default mode network connectivity in alzheimer's disease -a resting functional MRI and bayesian network study. Hum. Brain Mapp. DOI: 10.1002/hbm.21153 (2011) (Epub ahead of print)
75. Zhang L, Murata Y, Ishida R, Saitoh Y, Mizusawa H, Shibuya H. Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET. Nucl. Med. Commun. 22(7), 767-772 (2001)
76. Bonte FJ, Harris TS, Roney CA, Hynan LS. Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. J Nucl. Med. 45(5), 771-774 (2004)
77. McNeill R, Sare GM, Manoharan M et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol. Neurosurg. Psychiatry 78(4), 350-355 (2007)
78. Juh R, Pae CU, Kim TS, Lee CU, Choe B, Suh T. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci. Lett. 383(1-2), 22-27 (2005)
79. Peigneux P, Salmon E, Garraux G et al. Neural and cognitive bases of upper limb apraxia in corticobasal degeneration. Neurology 57(7), 1259-1268 (2001)
80. Teune LK, Bartels AL, de Jong BM et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov. Disord. 25(14), 2395-2404 (2010)
81. Quigley H, Colloby SJ, O'Brien JT. PET imaging of brain amyloid in dementia: a review. Int. J Geriatr. Psychiatry 26(10), 991-999 (2011)
82. Balasa M, Gelpi E, Antonell A et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology 76(20), 1720-1725 (2011)
83. Crystal HA, Horoupian DS, Katzman R, Jotkowitz S. Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome. Ann Neurol. 12(2), 186-188 (1982)
84. Libon DJ, Xie SX, Moore P et al. Patterns of neuropsychological impairment in frontotemporal dementia. Neurology 68(5), 369-375 (2007)
85. Lee SE, Rabinovici GD, Mayo MC et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 70(2), 327-340 (2011)